Insurers` Digital Strategies for Personal Customer Engagement
Survey shows insurance marketing executives across sectors believe buyer expectations for acceleration of digital distribution channels
Digital Transformation
Scaling & Digital Adaptations Hasten Insurance Technology Transformation
Successful scaling in insurance requires a balance between growth and stability. Companies need to expand their technological infrastructure
Agility Time for Blockchain in Insurance
Although blockchain offers enormous potential, it is not a silver bullet. Instead, it should be considered as part of a wider insurance digitization strategy
How Digital Transformation Accelerating the Insurers Growth?
Insurers surveyed by the Deloitte Center for Financial Services remain fairly bullish when it comes to their growth prospects for 2022
6 Key Actions a Technology Deployment for Insurers. Underwriting Transformation Survey
London Insurance Market have historically competed on expertise and not technology. The route to success was seen to be hiring the best underwriters
4 Ways Digital Transformation for business sustainability
Sustainability has rightly planted itself in the heart of boardroom and operational management conversations.
Artificial Intelligence, Digitization & Agent Experience Reshaping the Insurance
AI, Digitization & Agent Experience is changing the role of insurance, from pure risk protection towards predicting and preventing risks
- « Previous
- 1
- 2
Wealthy clients think about market swings, insurance gap, global instability, cyber intrusions, extreme weather, and the financial fallout of lawsuits, often all at once
European life insurers replace static SAA spreadsheets with advanced ALM tech to manage risk, capital, and yield under Solvency II and Solvency UK
Japan’s non-life insurance market — a global top-10 player and one of the largest in the region — as it continues to evolve through disciplined underwriting
AM Best shifts U.S. health insurance outlook to Negative, citing higher utilization, medical inflation, GLP-1 drug costs, and shifting Medicaid risk pools